Drug intelligence / Profile preview

Metaderm

Development stage
Phase 4
Lead developer
Haus Bioceuticals
Administration
Topical
01

Overview

**Metaderm** is a nonprescription topical homeopathic botanical cream marketed for temporary relief of psoriasis-associated dryness, itching, flaking, rash, redness, and skin irritation. The U.S. DailyMed label identifies eight homeopathic active botanical ingredients and states that the product has not been evaluated by the FDA for safety or efficacy. Metaderm cream was evaluated in an investigator-initiated, open-label University of Alabama at Birmingham study in plaque psoriasis, registered as NCT03597620. ([dailymed.nlm.nih.gov](https://dailymed.nlm.nih.gov/dailymed/fda/fdaDrugXsl.cfm?setid=737b1c88-1a43-68cf-e053-2991aa0a35b6))

Brand names
MetadermMetaDerm Psoriasis CreamMetaDerm Heal & Prevent Cream
Other names
HAT1 topical solutionHAT-1 topical solutionHAT 1 topical solutionHAT1 topical creamHAT-1 topical creamHAT 1 topical creamherbal anti-inflammatory treatment (HAT1)topical botanical complex, denoted HAT1
02

Targets

TLR (Toll-like receptors)TSLP (Thymic stromal lymphopoietin)

Beyond the preview

Go deeper on Metaderm.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Metaderm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call